| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.3 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |